Global Somatostatin Supply, Demand and Key Producers, 2024-2030

Description

The global Somatostatin market size is expected to reach $ 715 million by 2030, rising at a market growth of 10.9% CAGR during the forecast period (2024-2030).

Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.

China is the largest market, followed by Europe and India.

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

This report studies the global Somatostatin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Somatostatin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Somatostatin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Somatostatin total production and demand, 2019-2030, (K Pcs)
Global Somatostatin total production value, 2019-2030, (USD Million)
Global Somatostatin production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Somatostatin consumption by region & country, CAGR, 2019-2030 & (K Pcs)
U.S. VS China: Somatostatin domestic production, consumption, key domestic manufacturers and share
Global Somatostatin production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Pcs)
Global Somatostatin production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Somatostatin production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Pcs).

This reports profiles key players in the global Somatostatin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., Polypeptide Laboratories, Inc, SAMARTH, UBPL, HYBIO and TianTaiShan, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Somatostatin market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Somatostatin Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Somatostatin Market, Segmentation by Type
    0.25mg/pcs
    0.75mg/pcs
    3mg/pcs

Global Somatostatin Market, Segmentation by Application
    Hormonal Disorder
    Oncology
    Metabolic Disorder
    Others

Companies Profiled:
    Merck (Schweiz) AG
    SANOFI-AVENTIS FRANCE
    Lyomark Pharma GmbH
    ALFA WASSERMANN S.p.A.
    Polypeptide Laboratories, Inc
    SAMARTH
    UBPL
    HYBIO
    TianTaiShan
    Yangtze River
    Siyao
    Shuangcheng
    Hainan Zhonghe
    SL PHARM
    Wuhan Hualong
    Qingdao Guoda
    Chengdu Shengnuo
    Longjin

Key Questions Answered
1. How big is the global Somatostatin market?
2. What is the demand of the global Somatostatin market?
3. What is the year over year growth of the global Somatostatin market?
4. What is the production and production value of the global Somatostatin market?
5. Who are the key producers in the global Somatostatin market?

Table of Contents

1 Supply Summary
    1.1 Somatostatin Introduction
    1.2 World Somatostatin Supply & Forecast
        1.2.1 World Somatostatin Production Value (2019 & 2023 & 2030)
        1.2.2 World Somatostatin Production (2019-2030)
        1.2.3 World Somatostatin Pricing Trends (2019-2030)
    1.3 World Somatostatin Production by Region (Based on Production Site)
        1.3.1 World Somatostatin Production Value by Region (2019-2030)
        1.3.2 World Somatostatin Production by Region (2019-2030)
        1.3.3 World Somatostatin Average Price by Region (2019-2030)
        1.3.4 North America Somatostatin Production (2019-2030)
        1.3.5 Europe Somatostatin Production (2019-2030)
        1.3.6 China Somatostatin Production (2019-2030)
        1.3.7 Japan Somatostatin Production (2019-2030)
        1.3.8 India Somatostatin Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Somatostatin Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Somatostatin Major Market Trends

2 Demand Summary
    2.1 World Somatostatin Demand (2019-2030)
    2.2 World Somatostatin Consumption by Region
        2.2.1 World Somatostatin Consumption by Region (2019-2024)
        2.2.2 World Somatostatin Consumption Forecast by Region (2025-2030)
    2.3 United States Somatostatin Consumption (2019-2030)
    2.4 China Somatostatin Consumption (2019-2030)
    2.5 Europe Somatostatin Consumption (2019-2030)
    2.6 Japan Somatostatin Consumption (2019-2030)
    2.7 South Korea Somatostatin Consumption (2019-2030)
    2.8 ASEAN Somatostatin Consumption (2019-2030)
    2.9 India Somatostatin Consumption (2019-2030)

3 World Somatostatin Manufacturers Competitive Analysis
    3.1 World Somatostatin Production Value by Manufacturer (2019-2024)
    3.2 World Somatostatin Production by Manufacturer (2019-2024)
    3.3 World Somatostatin Average Price by Manufacturer (2019-2024)
    3.4 Somatostatin Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Somatostatin Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Somatostatin in 2023
        3.5.3 Global Concentration Ratios (CR8) for Somatostatin in 2023
    3.6 Somatostatin Market: Overall Company Footprint Analysis
        3.6.1 Somatostatin Market: Region Footprint
        3.6.2 Somatostatin Market: Company Product Type Footprint
        3.6.3 Somatostatin Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Somatostatin Production Value Comparison
        4.1.1 United States VS China: Somatostatin Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Somatostatin Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Somatostatin Production Comparison
        4.2.1 United States VS China: Somatostatin Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Somatostatin Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Somatostatin Consumption Comparison
        4.3.1 United States VS China: Somatostatin Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Somatostatin Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Somatostatin Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Somatostatin Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Somatostatin Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Somatostatin Production (2019-2024)
    4.5 China Based Somatostatin Manufacturers and Market Share
        4.5.1 China Based Somatostatin Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Somatostatin Production Value (2019-2024)
        4.5.3 China Based Manufacturers Somatostatin Production (2019-2024)
    4.6 Rest of World Based Somatostatin Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Somatostatin Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Somatostatin Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Somatostatin Production (2019-2024)

5 Market Analysis by Type
    5.1 World Somatostatin Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 0.25mg/pcs
        5.2.2 0.75mg/pcs
        5.2.3 3mg/pcs
    5.3 Market Segment by Type
        5.3.1 World Somatostatin Production by Type (2019-2030)
        5.3.2 World Somatostatin Production Value by Type (2019-2030)
        5.3.3 World Somatostatin Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Somatostatin Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hormonal Disorder
        6.2.2 Oncology
        6.2.3 Metabolic Disorder
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Somatostatin Production by Application (2019-2030)
        6.3.2 World Somatostatin Production Value by Application (2019-2030)
        6.3.3 World Somatostatin Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Merck (Schweiz) AG
        7.1.1 Merck (Schweiz) AG Details
        7.1.2 Merck (Schweiz) AG Major Business
        7.1.3 Merck (Schweiz) AG Somatostatin Product and Services
        7.1.4 Merck (Schweiz) AG Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Merck (Schweiz) AG Recent Developments/Updates
        7.1.6 Merck (Schweiz) AG Competitive Strengths & Weaknesses
    7.2 SANOFI-AVENTIS FRANCE
        7.2.1 SANOFI-AVENTIS FRANCE Details
        7.2.2 SANOFI-AVENTIS FRANCE Major Business
        7.2.3 SANOFI-AVENTIS FRANCE Somatostatin Product and Services
        7.2.4 SANOFI-AVENTIS FRANCE Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 SANOFI-AVENTIS FRANCE Recent Developments/Updates
        7.2.6 SANOFI-AVENTIS FRANCE Competitive Strengths & Weaknesses
    7.3 Lyomark Pharma GmbH
        7.3.1 Lyomark Pharma GmbH Details
        7.3.2 Lyomark Pharma GmbH Major Business
        7.3.3 Lyomark Pharma GmbH Somatostatin Product and Services
        7.3.4 Lyomark Pharma GmbH Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Lyomark Pharma GmbH Recent Developments/Updates
        7.3.6 Lyomark Pharma GmbH Competitive Strengths & Weaknesses
    7.4 ALFA WASSERMANN S.p.A.
        7.4.1 ALFA WASSERMANN S.p.A. Details
        7.4.2 ALFA WASSERMANN S.p.A. Major Business
        7.4.3 ALFA WASSERMANN S.p.A. Somatostatin Product and Services
        7.4.4 ALFA WASSERMANN S.p.A. Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 ALFA WASSERMANN S.p.A. Recent Developments/Updates
        7.4.6 ALFA WASSERMANN S.p.A. Competitive Strengths & Weaknesses
    7.5 Polypeptide Laboratories, Inc
        7.5.1 Polypeptide Laboratories, Inc Details
        7.5.2 Polypeptide Laboratories, Inc Major Business
        7.5.3 Polypeptide Laboratories, Inc Somatostatin Product and Services
        7.5.4 Polypeptide Laboratories, Inc Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Polypeptide Laboratories, Inc Recent Developments/Updates
        7.5.6 Polypeptide Laboratories, Inc Competitive Strengths & Weaknesses
    7.6 SAMARTH
        7.6.1 SAMARTH Details
        7.6.2 SAMARTH Major Business
        7.6.3 SAMARTH Somatostatin Product and Services
        7.6.4 SAMARTH Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 SAMARTH Recent Developments/Updates
        7.6.6 SAMARTH Competitive Strengths & Weaknesses
    7.7 UBPL
        7.7.1 UBPL Details
        7.7.2 UBPL Major Business
        7.7.3 UBPL Somatostatin Product and Services
        7.7.4 UBPL Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 UBPL Recent Developments/Updates
        7.7.6 UBPL Competitive Strengths & Weaknesses
    7.8 HYBIO
        7.8.1 HYBIO Details
        7.8.2 HYBIO Major Business
        7.8.3 HYBIO Somatostatin Product and Services
        7.8.4 HYBIO Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 HYBIO Recent Developments/Updates
        7.8.6 HYBIO Competitive Strengths & Weaknesses
    7.9 TianTaiShan
        7.9.1 TianTaiShan Details
        7.9.2 TianTaiShan Major Business
        7.9.3 TianTaiShan Somatostatin Product and Services
        7.9.4 TianTaiShan Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 TianTaiShan Recent Developments/Updates
        7.9.6 TianTaiShan Competitive Strengths & Weaknesses
    7.10 Yangtze River
        7.10.1 Yangtze River Details
        7.10.2 Yangtze River Major Business
        7.10.3 Yangtze River Somatostatin Product and Services
        7.10.4 Yangtze River Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Yangtze River Recent Developments/Updates
        7.10.6 Yangtze River Competitive Strengths & Weaknesses
    7.11 Siyao
        7.11.1 Siyao Details
        7.11.2 Siyao Major Business
        7.11.3 Siyao Somatostatin Product and Services
        7.11.4 Siyao Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Siyao Recent Developments/Updates
        7.11.6 Siyao Competitive Strengths & Weaknesses
    7.12 Shuangcheng
        7.12.1 Shuangcheng Details
        7.12.2 Shuangcheng Major Business
        7.12.3 Shuangcheng Somatostatin Product and Services
        7.12.4 Shuangcheng Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Shuangcheng Recent Developments/Updates
        7.12.6 Shuangcheng Competitive Strengths & Weaknesses
    7.13 Hainan Zhonghe
        7.13.1 Hainan Zhonghe Details
        7.13.2 Hainan Zhonghe Major Business
        7.13.3 Hainan Zhonghe Somatostatin Product and Services
        7.13.4 Hainan Zhonghe Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Hainan Zhonghe Recent Developments/Updates
        7.13.6 Hainan Zhonghe Competitive Strengths & Weaknesses
    7.14 SL PHARM
        7.14.1 SL PHARM Details
        7.14.2 SL PHARM Major Business
        7.14.3 SL PHARM Somatostatin Product and Services
        7.14.4 SL PHARM Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 SL PHARM Recent Developments/Updates
        7.14.6 SL PHARM Competitive Strengths & Weaknesses
    7.15 Wuhan Hualong
        7.15.1 Wuhan Hualong Details
        7.15.2 Wuhan Hualong Major Business
        7.15.3 Wuhan Hualong Somatostatin Product and Services
        7.15.4 Wuhan Hualong Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Wuhan Hualong Recent Developments/Updates
        7.15.6 Wuhan Hualong Competitive Strengths & Weaknesses
    7.16 Qingdao Guoda
        7.16.1 Qingdao Guoda Details
        7.16.2 Qingdao Guoda Major Business
        7.16.3 Qingdao Guoda Somatostatin Product and Services
        7.16.4 Qingdao Guoda Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Qingdao Guoda Recent Developments/Updates
        7.16.6 Qingdao Guoda Competitive Strengths & Weaknesses
    7.17 Chengdu Shengnuo
        7.17.1 Chengdu Shengnuo Details
        7.17.2 Chengdu Shengnuo Major Business
        7.17.3 Chengdu Shengnuo Somatostatin Product and Services
        7.17.4 Chengdu Shengnuo Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 Chengdu Shengnuo Recent Developments/Updates
        7.17.6 Chengdu Shengnuo Competitive Strengths & Weaknesses
    7.18 Longjin
        7.18.1 Longjin Details
        7.18.2 Longjin Major Business
        7.18.3 Longjin Somatostatin Product and Services
        7.18.4 Longjin Somatostatin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Longjin Recent Developments/Updates
        7.18.6 Longjin Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Somatostatin Industry Chain
    8.2 Somatostatin Upstream Analysis
        8.2.1 Somatostatin Core Raw Materials
        8.2.2 Main Manufacturers of Somatostatin Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Somatostatin Production Mode
    8.6 Somatostatin Procurement Model
    8.7 Somatostatin Industry Sales Model and Sales Channels
        8.7.1 Somatostatin Sales Model
        8.7.2 Somatostatin Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Somatostatin Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Somatostatin Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Somatostatin Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Somatostatin Production Value Market Share by Region (2019-2024)
    Table 5. World Somatostatin Production Value Market Share by Region (2025-2030)
    Table 6. World Somatostatin Production by Region (2019-2024) & (K Pcs)
    Table 7. World Somatostatin Production by Region (2025-2030) & (K Pcs)
    Table 8. World Somatostatin Production Market Share by Region (2019-2024)
    Table 9. World Somatostatin Production Market Share by Region (2025-2030)
    Table 10. World Somatostatin Average Price by Region (2019-2024) & (USD/Pcs)
    Table 11. World Somatostatin Average Price by Region (2025-2030) & (USD/Pcs)
    Table 12. Somatostatin Major Market Trends
    Table 13. World Somatostatin Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Pcs)
    Table 14. World Somatostatin Consumption by Region (2019-2024) & (K Pcs)
    Table 15. World Somatostatin Consumption Forecast by Region (2025-2030) & (K Pcs)
    Table 16. World Somatostatin Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Somatostatin Producers in 2023
    Table 18. World Somatostatin Production by Manufacturer (2019-2024) & (K Pcs)
    Table 19. Production Market Share of Key Somatostatin Producers in 2023
    Table 20. World Somatostatin Average Price by Manufacturer (2019-2024) & (USD/Pcs)
    Table 21. Global Somatostatin Company Evaluation Quadrant
    Table 22. World Somatostatin Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Somatostatin Production Site of Key Manufacturer
    Table 24. Somatostatin Market: Company Product Type Footprint
    Table 25. Somatostatin Market: Company Product Application Footprint
    Table 26. Somatostatin Competitive Factors
    Table 27. Somatostatin New Entrant and Capacity Expansion Plans
    Table 28. Somatostatin Mergers & Acquisitions Activity
    Table 29. United States VS China Somatostatin Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Somatostatin Production Comparison, (2019 & 2023 & 2030) & (K Pcs)
    Table 31. United States VS China Somatostatin Consumption Comparison, (2019 & 2023 & 2030) & (K Pcs)
    Table 32. United States Based Somatostatin Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Somatostatin Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Somatostatin Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Somatostatin Production (2019-2024) & (K Pcs)
    Table 36. United States Based Manufacturers Somatostatin Production Market Share (2019-2024)
    Table 37. China Based Somatostatin Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Somatostatin Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Somatostatin Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Somatostatin Production (2019-2024) & (K Pcs)
    Table 41. China Based Manufacturers Somatostatin Production Market Share (2019-2024)
    Table 42. Rest of World Based Somatostatin Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Somatostatin Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Somatostatin Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Somatostatin Production (2019-2024) & (K Pcs)
    Table 46. Rest of World Based Manufacturers Somatostatin Production Market Share (2019-2024)
    Table 47. World Somatostatin Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Somatostatin Production by Type (2019-2024) & (K Pcs)
    Table 49. World Somatostatin Production by Type (2025-2030) & (K Pcs)
    Table 50. World Somatostatin Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Somatostatin Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Somatostatin Average Price by Type (2019-2024) & (USD/Pcs)
    Table 53. World Somatostatin Average Price by Type (2025-2030) & (USD/Pcs)
    Table 54. World Somatostatin Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Somatostatin Production by Application (2019-2024) & (K Pcs)
    Table 56. World Somatostatin Production by Application (2025-2030) & (K Pcs)
    Table 57. World Somatostatin Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Somatostatin Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Somatostatin Average Price by Application (2019-2024) & (USD/Pcs)
    Table 60. World Somatostatin Average Price by Application (2025-2030) & (USD/Pcs)
    Table 61. Merck (Schweiz) AG Basic Information, Manufacturing Base and Competitors
    Table 62. Merck (Schweiz) AG Major Business
    Table 63. Merck (Schweiz) AG Somatostatin Product and Services
    Table 64. Merck (Schweiz) AG Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Merck (Schweiz) AG Recent Developments/Updates
    Table 66. Merck (Schweiz) AG Competitive Strengths & Weaknesses
    Table 67. SANOFI-AVENTIS FRANCE Basic Information, Manufacturing Base and Competitors
    Table 68. SANOFI-AVENTIS FRANCE Major Business
    Table 69. SANOFI-AVENTIS FRANCE Somatostatin Product and Services
    Table 70. SANOFI-AVENTIS FRANCE Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. SANOFI-AVENTIS FRANCE Recent Developments/Updates
    Table 72. SANOFI-AVENTIS FRANCE Competitive Strengths & Weaknesses
    Table 73. Lyomark Pharma GmbH Basic Information, Manufacturing Base and Competitors
    Table 74. Lyomark Pharma GmbH Major Business
    Table 75. Lyomark Pharma GmbH Somatostatin Product and Services
    Table 76. Lyomark Pharma GmbH Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Lyomark Pharma GmbH Recent Developments/Updates
    Table 78. Lyomark Pharma GmbH Competitive Strengths & Weaknesses
    Table 79. ALFA WASSERMANN S.p.A. Basic Information, Manufacturing Base and Competitors
    Table 80. ALFA WASSERMANN S.p.A. Major Business
    Table 81. ALFA WASSERMANN S.p.A. Somatostatin Product and Services
    Table 82. ALFA WASSERMANN S.p.A. Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. ALFA WASSERMANN S.p.A. Recent Developments/Updates
    Table 84. ALFA WASSERMANN S.p.A. Competitive Strengths & Weaknesses
    Table 85. Polypeptide Laboratories, Inc Basic Information, Manufacturing Base and Competitors
    Table 86. Polypeptide Laboratories, Inc Major Business
    Table 87. Polypeptide Laboratories, Inc Somatostatin Product and Services
    Table 88. Polypeptide Laboratories, Inc Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Polypeptide Laboratories, Inc Recent Developments/Updates
    Table 90. Polypeptide Laboratories, Inc Competitive Strengths & Weaknesses
    Table 91. SAMARTH Basic Information, Manufacturing Base and Competitors
    Table 92. SAMARTH Major Business
    Table 93. SAMARTH Somatostatin Product and Services
    Table 94. SAMARTH Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. SAMARTH Recent Developments/Updates
    Table 96. SAMARTH Competitive Strengths & Weaknesses
    Table 97. UBPL Basic Information, Manufacturing Base and Competitors
    Table 98. UBPL Major Business
    Table 99. UBPL Somatostatin Product and Services
    Table 100. UBPL Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. UBPL Recent Developments/Updates
    Table 102. UBPL Competitive Strengths & Weaknesses
    Table 103. HYBIO Basic Information, Manufacturing Base and Competitors
    Table 104. HYBIO Major Business
    Table 105. HYBIO Somatostatin Product and Services
    Table 106. HYBIO Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. HYBIO Recent Developments/Updates
    Table 108. HYBIO Competitive Strengths & Weaknesses
    Table 109. TianTaiShan Basic Information, Manufacturing Base and Competitors
    Table 110. TianTaiShan Major Business
    Table 111. TianTaiShan Somatostatin Product and Services
    Table 112. TianTaiShan Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. TianTaiShan Recent Developments/Updates
    Table 114. TianTaiShan Competitive Strengths & Weaknesses
    Table 115. Yangtze River Basic Information, Manufacturing Base and Competitors
    Table 116. Yangtze River Major Business
    Table 117. Yangtze River Somatostatin Product and Services
    Table 118. Yangtze River Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Yangtze River Recent Developments/Updates
    Table 120. Yangtze River Competitive Strengths & Weaknesses
    Table 121. Siyao Basic Information, Manufacturing Base and Competitors
    Table 122. Siyao Major Business
    Table 123. Siyao Somatostatin Product and Services
    Table 124. Siyao Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Siyao Recent Developments/Updates
    Table 126. Siyao Competitive Strengths & Weaknesses
    Table 127. Shuangcheng Basic Information, Manufacturing Base and Competitors
    Table 128. Shuangcheng Major Business
    Table 129. Shuangcheng Somatostatin Product and Services
    Table 130. Shuangcheng Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Shuangcheng Recent Developments/Updates
    Table 132. Shuangcheng Competitive Strengths & Weaknesses
    Table 133. Hainan Zhonghe Basic Information, Manufacturing Base and Competitors
    Table 134. Hainan Zhonghe Major Business
    Table 135. Hainan Zhonghe Somatostatin Product and Services
    Table 136. Hainan Zhonghe Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 137. Hainan Zhonghe Recent Developments/Updates
    Table 138. Hainan Zhonghe Competitive Strengths & Weaknesses
    Table 139. SL PHARM Basic Information, Manufacturing Base and Competitors
    Table 140. SL PHARM Major Business
    Table 141. SL PHARM Somatostatin Product and Services
    Table 142. SL PHARM Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 143. SL PHARM Recent Developments/Updates
    Table 144. SL PHARM Competitive Strengths & Weaknesses
    Table 145. Wuhan Hualong Basic Information, Manufacturing Base and Competitors
    Table 146. Wuhan Hualong Major Business
    Table 147. Wuhan Hualong Somatostatin Product and Services
    Table 148. Wuhan Hualong Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 149. Wuhan Hualong Recent Developments/Updates
    Table 150. Wuhan Hualong Competitive Strengths & Weaknesses
    Table 151. Qingdao Guoda Basic Information, Manufacturing Base and Competitors
    Table 152. Qingdao Guoda Major Business
    Table 153. Qingdao Guoda Somatostatin Product and Services
    Table 154. Qingdao Guoda Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 155. Qingdao Guoda Recent Developments/Updates
    Table 156. Qingdao Guoda Competitive Strengths & Weaknesses
    Table 157. Chengdu Shengnuo Basic Information, Manufacturing Base and Competitors
    Table 158. Chengdu Shengnuo Major Business
    Table 159. Chengdu Shengnuo Somatostatin Product and Services
    Table 160. Chengdu Shengnuo Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 161. Chengdu Shengnuo Recent Developments/Updates
    Table 162. Longjin Basic Information, Manufacturing Base and Competitors
    Table 163. Longjin Major Business
    Table 164. Longjin Somatostatin Product and Services
    Table 165. Longjin Somatostatin Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 166. Global Key Players of Somatostatin Upstream (Raw Materials)
    Table 167. Somatostatin Typical Customers
    Table 168. Somatostatin Typical Distributors
List of Figure
    Figure 1. Somatostatin Picture
    Figure 2. World Somatostatin Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Somatostatin Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Somatostatin Production (2019-2030) & (K Pcs)
    Figure 5. World Somatostatin Average Price (2019-2030) & (USD/Pcs)
    Figure 6. World Somatostatin Production Value Market Share by Region (2019-2030)
    Figure 7. World Somatostatin Production Market Share by Region (2019-2030)
    Figure 8. North America Somatostatin Production (2019-2030) & (K Pcs)
    Figure 9. Europe Somatostatin Production (2019-2030) & (K Pcs)
    Figure 10. China Somatostatin Production (2019-2030) & (K Pcs)
    Figure 11. Japan Somatostatin Production (2019-2030) & (K Pcs)
    Figure 12. India Somatostatin Production (2019-2030) & (K Pcs)
    Figure 13. Somatostatin Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 16. World Somatostatin Consumption Market Share by Region (2019-2030)
    Figure 17. United States Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 18. China Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 19. Europe Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 20. Japan Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 21. South Korea Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 22. ASEAN Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 23. India Somatostatin Consumption (2019-2030) & (K Pcs)
    Figure 24. Producer Shipments of Somatostatin by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Somatostatin Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Somatostatin Markets in 2023
    Figure 27. United States VS China: Somatostatin Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Somatostatin Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States VS China: Somatostatin Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 30. United States Based Manufacturers Somatostatin Production Market Share 2023
    Figure 31. China Based Manufacturers Somatostatin Production Market Share 2023
    Figure 32. Rest of World Based Manufacturers Somatostatin Production Market Share 2023
    Figure 33. World Somatostatin Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 34. World Somatostatin Production Value Market Share by Type in 2023
    Figure 35. 0.25mg/pcs
    Figure 36. 0.75mg/pcs
    Figure 37. 3mg/pcs
    Figure 38. World Somatostatin Production Market Share by Type (2019-2030)
    Figure 39. World Somatostatin Production Value Market Share by Type (2019-2030)
    Figure 40. World Somatostatin Average Price by Type (2019-2030) & (USD/Pcs)
    Figure 41. World Somatostatin Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 42. World Somatostatin Production Value Market Share by Application in 2023
    Figure 43. Hormonal Disorder
    Figure 44. Oncology
    Figure 45. Metabolic Disorder
    Figure 46. Others
    Figure 47. World Somatostatin Production Market Share by Application (2019-2030)
    Figure 48. World Somatostatin Production Value Market Share by Application (2019-2030)
    Figure 49. World Somatostatin Average Price by Application (2019-2030) & (USD/Pcs)
    Figure 50. Somatostatin Industry Chain
    Figure 51. Somatostatin Procurement Model
    Figure 52. Somatostatin Sales Model
    Figure 53. Somatostatin Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Companies Mentioned

Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin